RA
CVS icon

Rise Advisors’s CVS Health CVS Stock Holding History

Rise Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,152
Closed -$86.8K – 426
2025
Q3 		$86.8K Buy
1,152
+46
+4% +$3.15K 0.03% 175
2025
Q2 		$76.3K Buy
1,106
+14
+1% +$918 0.03% 185
2025
Q1 		$74K Buy
1,092
+8
+0.7% +$479 0.03% 181
2024
Q4 		$48.7K Sell
1,084
-83
-7% -$4.66K 0.02% 235
2024
Q3 		$73.4K Sell
1,167
-22
-2% -$1.28K 0.04% 174
2024
Q2 		$70.2K Sell
1,189
-1
-0.1% -$63 0.04% 183
2024
Q1 		$94.9K Buy
1,190
+682
+134% +$52.1K 0.05% 158
2023
Q4 		$40.1K Buy
508
+3
+0.6% +$214 0.03% 183
2023
Q3 		$35.3K Sell
505
-110
-18% -$7.79K 0.03% 173
2023
Q2 		$42.5K Sell
615
-2
-0.3% -$142 0.03% 163
2023
Q1 		$45.9K Buy
617
+72
+13% +$6.04K 0.03% 158
2022
Q4 		$50.8K Buy
545
+3
+0.6% +$289 0.04% 153
2022
Q3 		$52K Buy
542
+30
+6% +$2.97K 0.04% 148
2022
Q2 		$47K Buy
512
+114
+29% +$11.1K 0.05% 142
2022
Q1 		$40K Buy
398
+2
+0.5% +$210 0.04% 166
2021
Q4 		$40.8K Buy
+396
New +$36.6K 0.04% 170

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Rise Advisors's CVS Position: Q4 2025 in Review

Rise Advisors sold out of CVS Health (CVS) in Q4 2025, closing a stake of 1,152 shares — an estimated $86.8K sold.

Rise Advisors first reported a position in CVS in Q4 2021 and held it in 16 quarters. The position peaked at $94.9K in Q1 2024. 1,948 funds tracked by Wall St. Rank hold CVS as of Q4 2025.

  • Rise Advisors reported no remaining CVS Health position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 1,152 CVS Health shares in Q4 2025, an estimated $86.8K.
  • Rise Advisors first reported a position in CVS Health in Q4 2021 and held it in 16 quarters.
  • Rise Advisors's CVS Health position peaked at $94.9K in Q1 2024.
  • 1,948 funds tracked by Wall St. Rank held CVS Health as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.